雜志介紹

Expert Review Of Hematology雜志介紹

《Expert Review Of Hematology》是一本以English為主的未開(kāi)放獲取國(guó)際優(yōu)秀期刊，中文名稱(chēng)血液學(xué)專(zhuān)家評(píng)審，本刊主要出版、報(bào)道醫(yī)學(xué)-HEMATOLOGY領(lǐng)域的研究動(dòng)態(tài)以及在該領(lǐng)域取得的各方面的經(jīng)驗(yàn)和科研成果，介紹該領(lǐng)域有關(guān)本專(zhuān)業(yè)的最新進(jìn)展，探討行業(yè)發(fā)展的思路和方法，以促進(jìn)學(xué)術(shù)信息交流，提高行業(yè)發(fā)展。該刊已被國(guó)際權(quán)威數(shù)據(jù)庫(kù)SCIE收錄，為該領(lǐng)域相關(guān)學(xué)科的發(fā)展起到了良好的推動(dòng)作用，也得到了本專(zhuān)業(yè)人員的廣泛認(rèn)可。該刊最新影響因子為2.3，最新CiteScore 指數(shù)為4.7。

本刊近期中國(guó)學(xué)者發(fā)表的論文主要有：

• Risk factors for transplant-associated thrombotic microangiopathy (TA-TMA): a systematic review and meta-analysis

  Author: Guo, Mengting; Qi, Jiaqian; Hou, Qixiu; Li, Xueqian; Han, Yue

• Construction of a prognostic model of acute myeloid leukemia associated with immunogenic cell death

  Author: Sheng, Xinge; Lu, Jingyuan; Wang, Jiaqi; Fan, Kaiwen; Huang, Meijiao; Lu, Quanyi

• Efficacy and safety of caplacizumab in the treatment of thrombotic thrombocytopenic purpura: a systematic review and meta-analysis

  Author: He, Jingyi; Qi, Jiaqian; Han, Haohao; Xu, Xiaoyan; Li, Xueqian; Song, Xiaofei; Han, Yue

• Therapeutic mechanism of combined oral chelation therapy to maximize efficacy of iron removal in transfusion-dependent thalassemia major - a pilot study.

  Author: Lin CH^1,2, Chen X³, Wu CC³, Wu KH⁴, Song TS^5,6, Weng TF⁴, Hsieh YW⁷, Peng CT^4,8.

英文介紹

Expert Review Of Hematology雜志英文介紹

Advanced molecular research techniques have transformed hematology in recent years. With improved understanding of hematologic diseases, we now have the opportunity to research and evaluate new biological therapies, new drugs and drug combinations, new treatment schedules and novel approaches including stem cell transplantation. We can also expect proteomics, molecular genetics and biomarker research to facilitate new diagnostic approaches and the identification of appropriate therapies. Further advances in our knowledge regarding the formation and function of blood cells and blood-forming tissues should ensue, and it will be a major challenge for hematologists to adopt these new paradigms and develop integrated strategies to define the best possible patient care. Expert Review of Hematology (1747-4086) puts these advances in context and explores how they will translate directly into clinical practice.